Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
I-Corps Hub West accelerates deeptech commercialisation in western US
Black Sesame Technologies showcases robotics innovation at Asia Tech x Singapore
A new hope for AI development